|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
DE3374837D1
(en)
|
1982-02-17 |
1988-01-21 |
Ciba Geigy Ag |
Lipids in the aqueous phase
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
US4615885A
(en)
|
1983-11-01 |
1986-10-07 |
Terumo Kabushiki Kaisha |
Pharmaceutical composition containing urokinase
|
|
US4740461A
(en)
|
1983-12-27 |
1988-04-26 |
Genetics Institute, Inc. |
Vectors and methods for transformation of eucaryotic cells
|
|
US4959455A
(en)
|
1986-07-14 |
1990-09-25 |
Genetics Institute, Inc. |
Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
WO1988001649A1
(en)
|
1986-09-02 |
1988-03-10 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4912040A
(en)
|
1986-11-14 |
1990-03-27 |
Genetics Institute, Inc. |
Eucaryotic expression system
|
|
US5011912A
(en)
|
1986-12-19 |
1991-04-30 |
Immunex Corporation |
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
|
|
US4965195A
(en)
|
1987-10-26 |
1990-10-23 |
Immunex Corp. |
Interleukin-7
|
|
US4968607A
(en)
|
1987-11-25 |
1990-11-06 |
Immunex Corporation |
Interleukin-1 receptors
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5683888A
(en)
|
1989-07-22 |
1997-11-04 |
University Of Wales College Of Medicine |
Modified bioluminescent proteins and their use
|
|
US5292658A
(en)
|
1989-12-29 |
1994-03-08 |
University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center |
Cloning and expressions of Renilla luciferase
|
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
ES2284161T3
(es)
|
1990-01-12 |
2007-11-01 |
Amgen Fremont Inc. |
Generacion de anticuerpos xenogenicos.
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
WO1991018982A1
(en)
|
1990-06-05 |
1991-12-12 |
Immunex Corporation |
Type ii interleukin-1 receptors
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
AU8507191A
(en)
|
1990-08-29 |
1992-03-30 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
JP3126980B2
(ja)
|
1991-03-11 |
2001-01-22 |
ザ・ユニバーシテイ・オブ・ジヨージア・リサーチ・フアウンデーシヨン・インコーポレーテツド |
レニラ（ｒｅｎｉｌｌａ）ルシフェラーゼのクローニング及び発現
|
|
US6565841B1
(en)
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
WO1992022646A1
(en)
|
1991-06-14 |
1992-12-23 |
Dnx Corp. |
Production of human hemoglobin in transgenic pigs
|
|
JPH06508880A
(ja)
|
1991-07-08 |
1994-10-06 |
ユニバーシティ オブ マサチューセッツ アット アムハースト |
サーモトロピック液晶セグメント化ブロックコポリマー
|
|
US5470582A
(en)
|
1992-02-07 |
1995-11-28 |
Syntex (U.S.A.) Inc. |
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
|
|
ES2301158T3
(es)
|
1992-07-24 |
2008-06-16 |
Amgen Fremont Inc. |
Produccion de anticuerpos xenogenicos.
|
|
AU694745B2
(en)
|
1993-09-10 |
1998-07-30 |
Trustees Of Columbia University In The City Of New York, The |
Uses of green fluorescent protein
|
|
WO1995021191A1
(en)
|
1994-02-04 |
1995-08-10 |
William Ward |
Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein
|
|
US5777079A
(en)
|
1994-11-10 |
1998-07-07 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
|
EP0822830B1
(en)
|
1995-04-27 |
2008-04-02 |
Amgen Fremont Inc. |
Human anti-IL-8 antibodies, derived from immunized xenomice
|
|
US5874304A
(en)
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
|
US5804387A
(en)
|
1996-02-01 |
1998-09-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
FACS-optimized mutants of the green fluorescent protein (GFP)
|
|
US5876995A
(en)
|
1996-02-06 |
1999-03-02 |
Bryan; Bruce |
Bioluminescent novelty items
|
|
US5925558A
(en)
|
1996-07-16 |
1999-07-20 |
The Regents Of The University Of California |
Assays for protein kinases using fluorescent protein substrates
|
|
DE69739172D1
(de)
|
1996-08-08 |
2009-01-29 |
Amylin Pharmaceuticals Inc |
Regulation gastrointestinaler beweglichkeit
|
|
US5976796A
(en)
|
1996-10-04 |
1999-11-02 |
Loma Linda University |
Construction and expression of renilla luciferase and green fluorescent protein fusion genes
|
|
US7091183B1
(en)
|
1996-12-03 |
2006-08-15 |
Boston Medical Center Corporation |
Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)
|
|
ATE549918T1
(de)
|
1996-12-03 |
2012-04-15 |
Amgen Fremont Inc |
Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
|
|
AU5518798A
(en)
|
1996-12-03 |
1998-06-29 |
Trustees Of Boston University |
Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
|
|
WO1998026277A2
(en)
|
1996-12-12 |
1998-06-18 |
Prolume, Ltd. |
Apparatus and method for detecting and identifying infectious agents
|
|
PT1629849E
(pt)
|
1997-01-07 |
2013-07-09 |
Amylin Pharmaceuticals Llc |
Composições farmacêuticas que compreendem exendinas e seus agonistas
|
|
CA2196496A1
(en)
|
1997-01-31 |
1998-07-31 |
Stephen William Watson Michnick |
Protein fragment complementation assay for the detection of protein-protein interactions
|
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
DK1019077T4
(da)
|
1997-08-08 |
2011-03-07 |
Amylin Pharmaceuticals Inc |
Hidtil ukendte exendinagonistforbindelser
|
|
US7157555B1
(en)
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
|
JP2003522721A
(ja)
|
1997-11-14 |
2003-07-29 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
新規なエキセンジンアゴニスト化合物
|
|
JP2001523688A
(ja)
|
1997-11-14 |
2001-11-27 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
新規エキセンジン・アゴニスト化合物
|
|
US7223725B1
(en)
|
1997-11-14 |
2007-05-29 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
US7220721B1
(en)
|
1997-11-14 |
2007-05-22 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist peptides
|
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
|
ATE366115T1
(de)
|
1998-02-13 |
2007-07-15 |
Amylin Pharmaceuticals Inc |
Inotropische und diuretische effekte von exendin und glp-1
|
|
AU765703B2
(en)
|
1998-03-27 |
2003-09-25 |
Bruce J. Bryan |
Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
|
|
AU6294899A
(en)
|
1998-10-07 |
2000-04-26 |
Medical College Of Georgia Research Institute, Inc. |
Glucose-dependent insulinotropic peptide for use as an osteotropic hormone
|
|
PL205713B1
(pl)
|
1998-12-07 |
2010-05-31 |
Sod Conseils Rech Applic |
Związki stanowiące analogi GLP-1, kompozycje farmaceutyczne zawierające takie związki oraz zastosowanie tych związków
|
|
CA2358107C
(en)
|
1998-12-22 |
2011-08-23 |
Eli Lilly And Company |
Shelf-stable formulation of glucagon-like peptide-1
|
|
US20030087820A1
(en)
|
1999-01-14 |
2003-05-08 |
Young Andrew A. |
Novel exendin agonist formulations and methods of administration thereof
|
|
CN101181236A
(zh)
|
1999-01-14 |
2008-05-21 |
安米林药品公司 |
新型exendin激动剂制剂及其给药方法
|
|
EP1658856B1
(en)
|
1999-01-14 |
2010-03-17 |
Amylin Pharmaceuticals, Inc. |
Exendins for glucagon suppression
|
|
US20050272652A1
(en)
|
1999-03-29 |
2005-12-08 |
Gault Victor A |
Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
|
|
DE60012721T4
(de)
|
1999-03-29 |
2010-09-09 |
Uutech Ltd., Coleraine |
Analoge des magensaft inhibierenden peptides und ihre verwendung für die behandlung von diabetes
|
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
EP1246638B2
(en)
|
2000-01-10 |
2014-07-30 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of hypertriglyceridemia
|
|
HUP0204281A3
(en)
|
2000-01-27 |
2007-03-28 |
Lilly Co Eli |
Process for sulubilizing glucagon-like peptide 1 (glp-1) compounds
|
|
AU5675701A
(en)
|
2000-05-16 |
2001-11-26 |
Sanwa Kagaku Kenkyusho Co |
Agents for preventing or ameliorating insulin resistance and/or obesity
|
|
IL158418A0
(en)
|
2001-04-19 |
2004-05-12 |
Scripps Research Inst |
In vivo incorporation of unnatural amino acids
|
|
US20050159379A1
(en)
|
2001-05-18 |
2005-07-21 |
Sirna Therapeutics, Inc |
RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)
|
|
JP4566459B2
(ja)
|
2001-06-07 |
2010-10-20 |
株式会社日立製作所 |
表示装置
|
|
WO2003055914A2
(en)
*
|
2001-12-21 |
2003-07-10 |
7Tm Pharma A/S |
Modified receptors for the discovery of therapeutic ligands
|
|
CN1332711C
(zh)
|
2002-02-20 |
2007-08-22 |
埃米球科技有限公司 |
施用glp－1分子的方法
|
|
EP1506777A4
(en)
|
2002-05-22 |
2007-07-18 |
Sanwa Kagaku Kenkyusho Co |
MEANS FOR PREVENTING OR REDUCING FAT SUPPORT WITH A METHYLIDENHYDRAZIDE COMPOUND AS AN ACTIVE SUBSTANCE
|
|
EP1515746A2
(en)
*
|
2002-06-11 |
2005-03-23 |
Eisai Co. Ltd |
Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
|
|
CA2489323A1
(en)
|
2002-06-15 |
2003-12-24 |
Enteromed, Inc. |
Treatment of non-alcoholic fatty liver disease
|
|
JP2006213598A
(ja)
|
2003-03-19 |
2006-08-17 |
Sanwa Kagaku Kenkyusho Co Ltd |
ピラゾロピリミジン化合物及びその用途
|
|
JP4629047B2
(ja)
|
2003-06-12 |
2011-02-09 |
イーライ リリー アンド カンパニー |
Ｇｌｐ−１アナログ複合タンパク質
|
|
EP1663295A2
(en)
|
2003-09-01 |
2006-06-07 |
Novo Nordisk A/S |
Stable formulations of peptides
|
|
US20060094652A1
(en)
|
2004-02-11 |
2006-05-04 |
Levy Odile E |
Hybrid polypeptides with selectable properties
|
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
|
US7991890B2
(en)
|
2004-09-30 |
2011-08-02 |
Microsoft Corporation |
Game console communication with a device
|
|
AU2005298689A1
(en)
|
2004-10-25 |
2006-05-04 |
Cytos Biotechnology Ag |
Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
|
|
PT1831252E
(pt)
|
2004-12-22 |
2009-09-17 |
Lilly Co Eli |
Formulações de proteínas de fusão de análogos de glp-1
|
|
US20060275288A1
(en)
|
2005-01-20 |
2006-12-07 |
Grihalde Nelson D |
GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
|
|
BRPI0606992A2
(pt)
|
2005-02-11 |
2009-07-28 |
Amylin Pharmaceuticals Inc |
análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis
|
|
US8263545B2
(en)
|
2005-02-11 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
GIP analog and hybrid polypeptides with selectable properties
|
|
EP1882044A1
(en)
|
2005-05-11 |
2008-01-30 |
sanofi-aventis |
Use of a gip promoter polymorphism
|
|
WO2006125763A1
(en)
|
2005-05-25 |
2006-11-30 |
Novo Nordisk A/S |
Stabilized polypeptide formulations
|
|
WO2007028633A2
(en)
*
|
2005-09-08 |
2007-03-15 |
Uutech Limited |
Treatment of diabetes related obesity
|
|
EP2004238A2
(en)
|
2006-03-21 |
2008-12-24 |
Amylin Pharmaceuticals, Inc. |
Peptide-peptidase inhibitor conjugates and methods of using same
|
|
CA2657103A1
(en)
|
2006-07-07 |
2008-01-10 |
The Texas A&M University System |
Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis
|
|
EP2068910A2
(en)
|
2006-08-04 |
2009-06-17 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and exendin agonists and glp-1 receptor agonists for altering lipoprotein particle size and subclass composition
|
|
US8497240B2
(en)
|
2006-08-17 |
2013-07-30 |
Amylin Pharmaceuticals, Llc |
DPP-IV resistant GIP hybrid polypeptides with selectable properties
|
|
WO2008021560A2
(en)
|
2006-08-17 |
2008-02-21 |
Amylin Pharmaceuticals, Inc. |
Dpp-iv resistant gip hybrid polypeptides with selectable properties
|
|
US20090098130A1
(en)
|
2007-01-05 |
2009-04-16 |
Bradshaw Curt W |
Glucagon-like protein-1 receptor (glp-1r) agonist compounds
|
|
MX2009008241A
(es)
|
2007-02-15 |
2009-10-08 |
Univ Indiana Res & Tech Corp |
Co-agonistas de receptor de glucagon/glp-1.
|
|
EP2195034A2
(en)
|
2007-09-27 |
2010-06-16 |
Amylin Pharmaceuticals, Inc. |
Peptide-peptidase inhibitor conjugates and methods of making and using same
|
|
US20090144162A1
(en)
|
2007-11-29 |
2009-06-04 |
Neil Milne |
Transaction Security Method and Apparatus
|
|
GB0814068D0
(en)
|
2008-08-01 |
2008-09-10 |
Univ Ulster |
Active immunisation against GIP
|
|
KR20110043688A
(ko)
*
|
2008-08-07 |
2011-04-27 |
입센 파마 에스.에이.에스 |
포도당 의존적인 인슐린 분비 자극성 폴리펩타이드 유사체
|
|
CA2733006A1
(en)
|
2008-08-07 |
2010-02-11 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal
|
|
EA020018B1
(ru)
|
2008-08-07 |
2014-08-29 |
Ипсен Фарма С.А.С. |
Процессированные аналоги глюкозозависимого инсулинотропного полипептида
|
|
WO2010016936A1
(en)
|
2008-08-07 |
2010-02-11 |
Ipsen Pharma S.A.S. |
Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide
|
|
MX2011001031A
(es)
|
2008-08-07 |
2011-04-26 |
Ipsen Pharma Sas |
Analogos de polipeptidos insulinotropicos dependientes de glucosa.
|
|
WO2011014680A2
(en)
|
2009-07-31 |
2011-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gastric inhibitory peptide variants and their uses
|
|
EP2528618A4
(en)
|
2010-01-27 |
2015-05-27 |
Univ Indiana Res & Tech Corp |
GLUCAGON ANTAGONISTE AND GIP AGONISTS CONJUGATES AND COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES AND ADIPOSITAS
|
|
CA2798273A1
(en)
*
|
2010-05-04 |
2011-11-10 |
Merrimack Pharmaceuticals, Inc. |
Antibodies against epidermal growth factor receptor (egfr) and uses thereof
|
|
US9023986B2
(en)
|
2010-10-25 |
2015-05-05 |
Hoffmann-La Roche Inc. |
Glucose-dependent insulinotropic peptide analogs
|
|
WO2012088116A2
(en)
|
2010-12-22 |
2012-06-28 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting gip receptor activity
|
|
WO2012121302A1
(ja)
|
2011-03-08 |
2012-09-13 |
株式会社 三和化学研究所 |
分析方法
|
|
US9453062B2
(en)
|
2011-06-10 |
2016-09-27 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
|
|
CA2880929A1
(en)
|
2012-09-07 |
2014-03-13 |
Sanofi |
Fusion proteins for treating a metabolic syndrome
|
|
WO2015022420A1
(en)
|
2013-08-16 |
2015-02-19 |
Medimmune Limited |
Gip and glp-1 receptor dual-agonists for the treatment of diabetes
|
|
WO2015081440A1
(en)
|
2013-12-04 |
2015-06-11 |
Innovative Targeting Solutions Inc. |
G-protein coupled receptor agonists and methods
|
|
CN106068127B
(zh)
|
2013-12-13 |
2020-06-19 |
诺和诺德保健股份有限公司 |
蛋白质的硫醚缀合方法
|
|
HUE067414T2
(hu)
*
|
2013-12-17 |
2024-10-28 |
Mhs Care Innovation Llc |
Készítmények és eljárások zsírszövet felhalmozódásának kezelésére
|
|
US10570184B2
(en)
|
2014-06-04 |
2020-02-25 |
Novo Nordisk A/S |
GLP-1/glucagon receptor co-agonists for medical use
|
|
AR104932A1
(es)
|
2015-06-22 |
2017-08-23 |
Lilly Co Eli |
Compuestos co-agonistas del glucagón y péptido-1 similar al glugacón (glp-1)
|
|
TWI622596B
(zh)
|
2015-10-26 |
2018-05-01 |
美國禮來大藥廠 |
升糖素受體促效劑
|
|
CR20180378A
(es)
|
2015-12-23 |
2018-12-06 |
Amgen Inc |
Método para tratar o mejorar trastornos metabólicos con proteínas de unión para el receptor peptídico inhibidor gástrico (gipr) en combinación con agosnistas de glp-1
|
|
KR102781241B1
(ko)
|
2017-01-17 |
2025-03-14 |
암젠 인크 |
위 저해 펩타이드 수용체(gipr)에 대한 길항제에 접합된 glp-1 수용체 작용제를 사용하여 대사 장애를 치료 또는 개선하는 방법
|
|
MX2019013919A
(es)
|
2017-06-20 |
2020-01-21 |
Amgen Inc |
Metodo para tratar o mejorar trastornos metabolicos con proteinas de union para el receptor peptidico inhibidor gastrico (gipr) en combinacion con agonistas de glp-1.
|
|
JP7250706B2
(ja)
|
2017-06-21 |
2023-04-03 |
アムジエン・インコーポレーテツド |
胃抑制ペプチド受容体（ｇｉｐｒ）に対するアンタゴニスト結合タンパク質／ｇｌｐ－１受容体アゴニスト融合タンパク質を使用した代謝障害の治療又は寛解方法
|
|
FI3661562T3
(fi)
*
|
2017-08-04 |
2024-12-09 |
Amgen Inc |
Cys-mab:ien konjugointimenetelmä
|
|
EP3934679A1
(en)
*
|
2019-03-08 |
2022-01-12 |
Amgen Inc. |
Growth differentiation factor 15 combination therapy
|